ZSCAN31: A Potential Drug Target and Biomarker (G64288)

Target Name: ZSCAN31

NCBI ID: G64288

ZSCAN31

ZSCAN31: A Potential Drug Target and Biomarker

Zinc finger and SCAN domain containing 31 (ZSCAN31) is a protein that has been identified as a potential drug target and biomarker. The ZSCAN31 protein is a 31-kDa protein that is expressed in various tissues and cells, including brain, muscle, heart, and placenta. It is composed of a zinc finger and a SCAN domain, which give it its unique structure and function.

The zinc finger protein is a family of transmembrane proteins that are characterized by a conserved zinc finger motif. This motif is responsible for the protein's ability to interact with zinc ions, which are essential for various cellular processes. The SCAN domain is a conserved protein that is characterized by a specific sequence that is responsible for its ability to interact with the zinc finger motif.

ZSCAN31 is a member of the ZSCAN gene family, which is known for the production of zinc finger proteins. ZSCAN31 is expressed in various tissues and cells and is involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

One of the most promising aspects of ZSCAN31 is its potential as a drug target. The zinc finger and SCAN domain give it unique structure and function that make it an attractive target for drug development. The zinc finger motif is known to be involved in various cellular processes, including signaling, and the SCAN domain is involved in the interaction with the zinc finger motif. These properties make ZSCAN31 an attractive target for drugs that are designed to modulate these processes.

In addition to its potential as a drug target, ZSCAN31 has also been identified as a potential biomarker. The zinc finger and SCAN domain give ZSCAN31 a unique structure that makes it easy to detect and measure. This makes it an attractive target for the development of diagnostic tools that can be used to diagnose and monitor various diseases.

One of the most promising aspects of ZSCAN31 is its potential as a drug target is its ability to modulate cellular processes that are involved in various diseases, including cancer, neurodegenerative diseases, and metabolic diseases. The zinc finger and SCAN domain give ZSCAN31 unique structure and function that make it an attractive target for drugs that are designed to modulate these processes.

In conclusion, ZSCAN31 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function make it an attractive target for drug development, and its potential as a biomarker makes it an attractive target for diagnostic tools that can be used to monitor and diagnose various diseases. Further research is needed to fully understand the properties and function of ZSCAN31, and to determine its potential as a drug target and biomarker.

Protein Name: Zinc Finger And SCAN Domain Containing 31

Functions: May function as a transcription factor. May be involved in the development of multiple embryonic organs

The "ZSCAN31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets